Side Effects Following Administration of the First Dose of Oxford-AstraZeneca’s Covishield Vaccine in Bangladesh: A Cross-Sectional Study
Nishat Jahan(University of Asia Pacific), Nur Alam(International Centre for Diarrhoeal Disease Research), A. S. M. Roknuzzaman(University of Asia Pacific), Mahtab Hossain Chowdhury(University of Asia Pacific), Sadia Afruz Ether(Daffodil International University), Humayra Zaman Himi(University of Asia Pacific), Rapty Sarker(West Virginia University), Poushali Saha(University of Dhaka), Fahad Imtiaz Rahman(University of Dhaka), Mostafa Moin Uddin(Directorate General of Health Services), K. Ziyaul Haq(University of Asia Pacific), Khondoker Tashya Kalam(University of Asia Pacific), Md. Nazmul Hossain(University of Asia Pacific), Julkar Nyeen(University of Asia Pacific)
Cited by 24
Related Papers
The WHO has declared the end of pandemic phase of COVID‐19: Way to come back in the normal life
|Health Science Reports|2023|115
The WHO declares COVID-19 is no longer a public health emergency of international concern: benefits, challenges, and necessary precautions to come back to normal life
|International Journal of Surgery|2023|64
Upsurge of dengue outbreaks in several WHO regions: Public awareness, vector control activities, and international collaborations are key to prevent spread
|Health Science Reports|2024|58